scholarly article | Q13442814 |
P50 | author | Arti Hurria | Q88804859 |
Martine Extermann | Q90278284 | ||
Betty Ferrell | Q90752138 | ||
Kenneth E Schmader | Q91406944 | ||
Richard L Schilsky | Q98902663 | ||
Hyman B Muss | Q104758257 | ||
Cancer and Aging Research Group | Q114373343 | ||
P2093 | author name string | Edward L Trimble | |
William Dale | |||
Harvey J Cohen | |||
Supriya G Mohile | |||
Susan G Nayfield | |||
Basil A Eldadah | |||
P2860 | cites work | Frailty in older adults: evidence for a phenotype | Q28205094 |
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B | Q28247684 | ||
Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress | Q33209607 | ||
The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel | Q33349424 | ||
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer | Q33372496 | ||
Senescent cells as a source of inflammatory factors for tumor progression | Q33833881 | ||
The age of cancer | Q34088387 | ||
Cellular senescence, cancer and aging: the telomere connection | Q34416433 | ||
Delirium in older persons | Q34502517 | ||
The regulation of INK4/ARF in cancer and aging | Q34575801 | ||
Participation in cancer clinical trials: race-, sex-, and age-based disparities | Q80179103 | ||
The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer | Q80353279 | ||
Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6 | Q80422502 | ||
The origins of age-related proinflammatory state | Q81079607 | ||
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762) | Q82985575 | ||
Hospitalization and change in body composition and strength in a population-based cohort of older persons | Q34685870 | ||
Adjuvant chemotherapy in older women with early-stage breast cancer | Q34858284 | ||
Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401 | Q34879258 | ||
Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes | Q35051336 | ||
Polypharmacy in older adults with cancer | Q35584088 | ||
Symptom management in the elderly cancer patient: fatigue, pain, and depression | Q35840887 | ||
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study | Q36760924 | ||
Comprehensive geriatric assessment for older patients with cancer | Q36815525 | ||
Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine | Q37104269 | ||
Prevalence of cognitive impairment without dementia in the United States | Q37161762 | ||
Cognitive effects of hormonal therapy in older adults | Q37332605 | ||
Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study | Q37334738 | ||
Acute myelogenous leukemia in older adults | Q37413855 | ||
Prognostic significance of potential frailty criteria. | Q37435810 | ||
Barriers to Enrollment of Elderly Adults in Early-Phase Cancer Clinical Trials | Q37476974 | ||
Multidimensional geriatric evaluation for older cancer patients as a clinical and research tool | Q37501072 | ||
Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries | Q37608744 | ||
Cancer treatment in older adults: implications for psychosocial research | Q37685235 | ||
Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction | Q37732629 | ||
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial | Q38392753 | ||
Mentoring junior faculty in geriatric oncology: report from the Cancer and Aging Research Group | Q39744643 | ||
Cancer in home care: unintended weight loss and ethical challenges. A cross-sectional study of older people at 11 sites in Europe | Q39938753 | ||
Future of cancer incidence in the United States: burdens upon an aging, changing nation | Q39983611 | ||
Adverse drug reaction risk factors in older outpatients. | Q40466669 | ||
Serum IL-6 level and the development of disability in older persons | Q40809943 | ||
Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care | Q44614363 | ||
Comorbidity and functional status are independent in older cancer patients | Q44747457 | ||
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer | Q45041166 | ||
Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia | Q45079412 | ||
5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study | Q45233228 | ||
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older. | Q45995909 | ||
Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center | Q46195964 | ||
Social Networks, Institutionalization, and Mortality Among Elderly People in the United States | Q46310007 | ||
Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer | Q46427019 | ||
The effect of comorbidity on 3-year survival of women with primary breast cancer | Q46637774 | ||
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study | Q46817220 | ||
Treatment of depressive conditions in later life: real-world light for dark (or dim) tunnels | Q51941841 | ||
Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. | Q51960759 | ||
Barriers to clinical trial participation by older women with breast cancer. | Q53860521 | ||
Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic Disability | Q58071352 | ||
Importance of functional measures in predicting mortality among older hospitalized patients | Q74471636 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ageing research | Q110477187 |
P304 | page(s) | 581-589 | |
P577 | publication date | 2012-03-27 | |
P1433 | published in | Journal of the National Cancer Institute | Q400279 |
P1476 | title | Biological, clinical, and psychosocial correlates at the interface of cancer and aging research | |
P478 | volume | 104 |
Q90318928 | A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax) |
Q50117074 | Cancer in the older adult: Implications for therapy and future research. |
Q39019794 | Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study |
Q52663666 | Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer. |
Q34031134 | Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations |
Q34155010 | Determining chemotherapy tolerance in older patients with cancer |
Q90181661 | Developing a clinical and biological measures of aging core: Cancer and Aging Research Group infrastructure |
Q37325103 | Differences in the symptom experience of older oncology outpatients |
Q55093285 | Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014. |
Q37133361 | Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer. |
Q92658251 | Effects of cancer history on functional age and mortality |
Q89224246 | Functional trajectories before and after a new cancer diagnosis among community-dwelling older adults |
Q36242685 | Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts. |
Q90359207 | Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policy |
Q37082755 | Geriatric oncology research to improve clinical care |
Q38869525 | How should older adults with cancer be evaluated for frailty? |
Q30250334 | Improving the quality of survivorship for older adults with cancer |
Q47649253 | Integrating Geriatric Principles into Critical Care Medicine: The Time is Now. |
Q37143527 | Interventions to improve the quality of life and survivorship of older adults with cancer: The funding landscape at NIH, ACS and PCORI. |
Q34902002 | Models of Care in Geriatric Oncology |
Q47630207 | Oncologists' End of Life Treatment Decisions. |
Q34514273 | Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates |
Q48395650 | Palliative chemotherapy in elderly patients with metastatic colorectal cancer: do we know how it should be used? |
Q88755207 | Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology |
Q89187256 | Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary |
Q37156456 | Prevalence of aging population in the Middle East and its implications on cancer incidence and care |
Q34386081 | Research priorities in geriatric oncology for 2013 and beyond. |
Q34682115 | Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study |
Q41682625 | Special Issues in Older Women with Breast Cancer |
Q57653813 | Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study |
Q38522966 | Symptoms: Fatigue and Cognitive Dysfunction |
Q34345447 | Testing the differential effects of symptom management interventions in cancer |
Q26778666 | The Crossroads of Geriatric Cardiology and Cardio-Oncology |
Q38132244 | The challenges of individualized care for older patients with localized breast cancer |
Q37659124 | Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer. |
Search more.